BioCentury
ARTICLE | Clinical News

Geron preclinical data

November 15, 2004 8:00 AM UTC

In a mouse model of ovarian carcinoma, GRN163L, a lipidated telomerase inhibitor, in combination with Taxol decreased tumor burden in 2 of 9 mice. Both GRN163L and Taxol given alone prevented tumor ...